These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10780724)

  • 1. Increased incidence of peripheral neuropathy with co-administration of stavudine and isoniazid in HIV-infected individuals.
    Breen RA; Lipman MC; Johnson MA
    AIDS; 2000 Mar; 14(5):615. PubMed ID: 10780724
    [No Abstract]   [Full Text] [Related]  

  • 2. Excess peripheral neuropathy in patients treated with hydroxyurea plus didanosine and stavudine for HIV infection.
    Cepeda JA; Wilks D
    AIDS; 2000 Feb; 14(3):332-3. PubMed ID: 10716516
    [No Abstract]   [Full Text] [Related]  

  • 3. Stavudine-associated peripheral neuropathy in zidovudine-naïve patients: effect of stavudine exposure and antiretroviral experience.
    Scarsella A; Coodley G; Shalit P; Anderson R; Fisher RL; Liao Q; Ross LL; Hernandez JE
    Adv Ther; 2002; 19(1):1-8. PubMed ID: 12008857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans.
    Wadley AL; Cherry CL; Price P; Kamerman PR
    J Pain Symptom Manage; 2011 Apr; 41(4):700-6. PubMed ID: 21145196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea.
    Moore RD; Wong WM; Keruly JC; McArthur JC
    AIDS; 2000 Feb; 14(3):273-8. PubMed ID: 10716503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time for a change?
    Little S; del Rio C
    AIDS Clin Care; 1998 Dec; 10(12):92, 98. PubMed ID: 11366070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
    Cherry CL; Affandi JS; Imran D; Yunihastuti E; Smyth K; Vanar S; Kamarulzaman A; Price P
    Neurology; 2009 Jul; 73(4):315-20. PubMed ID: 19636052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.
    Kiwuwa-Muyingo S; Kikaire B; Mambule I; Musana H; Musoro G; Gilks CF; Levin JB; Walker AS
    AIDS; 2014 Nov; 28(17):2579-88. PubMed ID: 25574960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief Report: Demographic and Genetic Associations With Markers of Small and Large Fiber Sensory Neuropathy in HIV Patients Treated Without Stavudine.
    Safri AY; Gaff J; Octaviana F; Setiawan DD; Imran D; Cherry CL; Laws SM; Price P
    J Acquir Immune Defic Syndr; 2020 Dec; 85(5):612-616. PubMed ID: 32925363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy.
    Brew BJ; Tisch S; Law M
    AIDS; 2003 May; 17(7):1094-6. PubMed ID: 12700465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a reduced dose of stavudine on the incidence and severity of peripheral neuropathy in HIV-infected adults in South Africa.
    Pahuja M; Grobler A; Glesby MJ; Karim F; Parker G; Gumede S; Naidoo K
    Antivir Ther; 2012; 17(4):737-43. PubMed ID: 22414588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda.
    van Griensven J; Zachariah R; Rasschaert F; Mugabo J; Atté EF; Reid T
    Trans R Soc Trop Med Hyg; 2010 Feb; 104(2):148-53. PubMed ID: 19732926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study.
    Rutschmann OT; Vernazza PL; Bucher HC; Opravil M; Ledergerber B; Telenti A; Malinverni R; Bernasconi E; Fagard C; Leduc D; Perrin L; Hirschel B
    AIDS; 2000 Sep; 14(14):2145-51. PubMed ID: 11061656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetic variation influences sensory neuropathy occurrence in Southern Africans treated with stavudine-containing antiretroviral therapy.
    Moketla MB; Wadley AL; Kamerman P; de Assis Rosa D
    PLoS One; 2018; 13(10):e0204111. PubMed ID: 30273369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individuals.
    Brambilla AM; Novati R; Calori G; Meneghini E; Vacchini D; Luzi L; Castagna A; Lazzarin A
    AIDS; 2003 Sep; 17(13):1993-5. PubMed ID: 12960836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe toxicity and polymerase-γ gene abnormalities in Malawian adults on stavudine-based antiretroviral therapy.
    van Oosterhout JJ; Gardner K; Mallewa J; Kaunda S; Kampira E; Payne B; Heyderman RS; Chinnery P
    Pharmacogenet Genomics; 2013 Nov; 23(11):624-6. PubMed ID: 23962909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Adverse Drug Reaction Profiles in Patients on Antiretroviral and Antitubercular Treatment in Zimbabwe.
    Masuka JT; Chipangura P; Nyambayo PP; Stergachis A; Khoza S
    Clin Drug Investig; 2018 Jan; 38(1):9-17. PubMed ID: 28965312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral neuropathy in patients with HIV infection: consider dual pathology.
    Miller RF; Bunting S; Sadiq ST; Manji H
    Sex Transm Infect; 2002 Dec; 78(6):462-3. PubMed ID: 12473814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-onset severe isoniazid-induced motor-dominant neuropathy: a case report.
    Zaoui A; Abdelghani A; Ben Salem H; Ouanes W; Hayouni A; Khachnaoui F; Rejeb N; Benzarti M
    East Mediterr Health J; 2012 Mar; 18(3):298-9. PubMed ID: 22574487
    [No Abstract]   [Full Text] [Related]  

  • 20. [Isoniazid induced neuropathy: consider prevention].
    Steichen O; Martinez-Almoyna L; De Broucker T
    Rev Mal Respir; 2006 Apr; 23(2 Pt 1):157-60. PubMed ID: 16788441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.